2018
Our Ethical Obligation to Treat Opioid Use Disorder in Prisons: A Patient and Physician's Perspective
Bone C, Eysenbach L, Bell K, Barry DT. Our Ethical Obligation to Treat Opioid Use Disorder in Prisons: A Patient and Physician's Perspective. The Journal Of Law, Medicine & Ethics 2018, 46: 268-271. PMID: 30146992, DOI: 10.1177/1073110518782933.Peer-Reviewed Original ResearchConceptsOpioid use disorderUse disordersHepatitis C transmissionMedication-assisted treatmentHealth care providersPublic health threatLower ratesPoor outcomeOpioid epidemicImproved outcomesOpioid overdoseCare providersPhysician perspectivesLower riskC transmissionTreatment approachesDrug useHealth disparitiesInfectious diseasesHealth threatAccidental deathGold standardDisordersOverdoseIncarcerated individuals
2012
Counseling and Directly Observed Medication for Primary Care Buprenorphine Maintenance
Moore BA, Barry DT, Sullivan LE, O'Connor PG, Cutter CJ, Schottenfeld RS, Fiellin DA. Counseling and Directly Observed Medication for Primary Care Buprenorphine Maintenance. Journal Of Addiction Medicine 2012, 6: 205-211. PMID: 22614936, PMCID: PMC3419276, DOI: 10.1097/adm.0b013e3182596492.Peer-Reviewed Original ResearchConceptsCognitive behavioral therapyPhysician managementObserved medicationBaseline characteristicsCBT sessionsOpioid-negative urinesIndividual CBT sessionsBuprenorphine maintenanceOpioid useMedication adherencePatient satisfactionPrimary careImproved outcomesTreatment outcomesSession attendanceNegative urineTreatment groupsGreater abstinenceCounseling intensityDrug useTherapist availabilityMedicationsBuprenorphinePatientsIndependent effects